New book by Larry Connors Click here Improve your trading - See how
DATE POSTED: 14-AUG-08
AGENCY: Department of the Navy
OFFICE ADDRESS: 1681 NELSON ST FT DETRICK, MD 21702-9203
SUBJECT: Notice of Intent to Sole Source Blood Bank Analyzer to Immucor Inc.
CLASSIFICATION CODE: 65 - Medical, dental & veterinary equipment & supplies
SOLICITATION NUMBER: N62645-08-T-0233
CONTACT: CHRISTINA BOYD-BROWN, CONTRACT SPECIALIST, PHONE 301-619-2059, FAX 301-619-1132, EMAIL CHRISTINA.BOYD-BROWN@MED.NAVY.MIL - BURZIE C BAKER III, CONTRACTING OFFICER, PHONE 301-619-0707, FAX 301-619-2925, EMAIL BURZIE.BAKER@MED.NAVY.MIL
SETASIDE: N/A
PLACE OF PERFORMANCE ADDRESS: 1681 Nelson StreetFort Detrick, MD
PLACE OF PERFORMANCE ZIPCODE: 21702
PLACE OF PERFORMANCE COUNTRY: US
NOTICE TEXT: Department of the Navy Bureau of Medicine and Surgery NMLC The Naval Medical Logistics Command intends to negotiate on a sole source basis (IAW FAR 13.501) with Immucor Inc. 3130 Gateway Dr. P.O. Box 5625, Norcross, GA 30091-5625 as the only responsible source that can provide a Blood Bank Analyzer. Having two compatible machines working side by side will allow for the elimination of delays due to instrument malfunction, and will increase the testing capacity significantly. Furthermore, the ability to use reagents and consumables interchangeably between the two machines will simplify operations and thus reduce error. The machine shall but is not limited to the following requirements: A) Test blood products for: a. ABO-Rh b. Antibody screen c. CMV d. Syphilis B) Have the ability to access samples and reagents without interruption while performing multiple tests on each sample and view results while running C) Have an Intuitive interface a. Touch-screen color monitor b. Digital images of results c. Integrated help functions. D) Be compatible with existing Galileo System-64999 reagents and consumables E) Operate from a line voltage of 115 VAC + 10%, 60 + 2 Hz Based on the above information, it has been determined that the only technically acceptable Galileo System-64999 as produced by Immucor Inc satisfies these requirements. Regulatory Requirements: The system and all its components shall be compliant with the Food and Drug Administration (FDA) requirements to market and deliver medical products for use in the United States of America; even should delivery be requested outside of the United States. The claims made for the product shall comply with the regulations of the FDA with respect to products for marketing and delivery of a medical product for use in the United States of America, even should delivery be requested outside of the United States. This acquisition is being conducted under simplified acquisition procedures. There are no set-aside restrictions for this requirement. The intended procurement will be classified under North American Industry Classification System (NAICS) 423450 with a Small Business Size Standard of 500 employees. This notice of intent is not a request for competitive proposals and no solicitation document exists for this requirement. However, parties interested in responding to this notice shall submit technical data, including cost, sufficient to determine capability in providing the same product. All capability statements received by closing of this notification of this synopsis will be considered by the Government. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Submit email capability statements (using PDF, MS Word, Excel attachments) to Christina Boyd-Brown at christina.boyd-brown@med.navy.mil. Fax quotes may be sent to 301-619-1132 Attn: Christina Boyd-Brown. Email statements are preferred. Statements are due not later than 4:00 P.M. EST on 22 August 2008. No phone calls accepted.
INTERNET ADDRESS: https://www.fbo.gov/spg/DON/BUMED/N62645/N62645-08-T-0233/listing.html Provided by Federal Information & News Dispatch, Inc. (FIND) 202-429-5944
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
15260 Ventura Blvd., Ste. 2200
Sherman Oaks, CA 91403
© Copyright 2009 The Connors Group, Inc.
